Research Studies

Status: Recruiting
Study area: Oncology
Principal investigator: Leanna J. Standish, ND, PhD, LAc, FABNO; M. Robyn Andersen, PhD
Funded by: Primary funding by: NIH/NCCAM Grant No. 1R01AT005873; Study Expansion funding by: Lotte & John Hecht Foundation
Project period: 8/1/10 – 12/31/18

PURPOSE: This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrative Oncology (IO) and their effects on breast cancer patients in community settings.
Clinicaltrials.gov: NCT-1366248

Status: Recruiting
Study area: Neurology
Principal investigator: Laurie K Mischley, ND
Project period: 03/08/2013-03/31/2018

The goal of this PD study is to collect as much data as possible over a five-year period with the hope of finding dietary and lifestyle factors associated with a slower disease progression.
To participate in this study please email neuroresearch[at]bastyr[dot]edu

Status: Recruiting
Study area: Neurology
Principal investigator: Laurie Mischley, ND
Project period: 09/01/2012 - 08/31/2017

Multiple sclerosis is often said to be an incurable, progressive, and degenerative disease. It is our hypothesis that some of you do not, or will not, have a progressive disease. The goal of this MS study is to collect as much data as possible over a five-year period with the hope of fiding dietary and lifestyle factors associated with a slower disease progression.

Status: Recruiting
Study area: Oncology
Principal investigator: Leanna J. Standish, ND, PhD, LAc, FABNO
Co-investigator(s): M. Robyn Andersen, PhD
Project period: August 1, 2010, to March 31, 2015

Prospective Matched Controlled Outcomes study is funded by NIH/NCCAM and conducted by Bastyr University Research Institute and Fred Hutchinson Cancer Research Center.

Status: Active
Study area: Neurology
Principal investigator: Laurie Mischley, ND, MPH
Funded by: NIH/NCCAM
Project period: 01/01/10 - 12/31/14

Parkinson's disease (PD) is considered a progressive and irreversible neurodegenerative disease. Current therapies improve disease symptoms, however none alter the underlying degenerative course. Research suggests the loss of brain glutathione, a powerful antioxidant, is one of the earliest changes to occur in the brain of PD patients and the magnitude of glutathione depletion parallels the severity of PD. This study will look at the use of intranasal glutathione in PD patients to determine safety, tolerability, and the impact on PD symptoms.

Status: Active
Study area: Oncology
Principal investigator: Leanna Standish, ND, PhD, LAc, FABNO; Mary L. (Nora) Disis, MD
Co-investigator(s): Lupe Salazar, MD, Hailing Lu, MD, PhD, Erin Sweet, ND
Funded by: NIH/NCCAM/NCI (U19) Partnership with University of Washington
Project period: 09/29/2010 - 08/31/2014

A Clinical Trial of Mushroom (PSK) for Treatment of Breast Cancer, The Bastyr University/University of Washington PCCTR Oncomycology Research Center will investigate the immunologic and antitumor effects of Trametes versicolor (Tv) a traditional Chinese medicine medicinal mushroom, for use in the treatment of breast cancer patients in the U.S. This study is not yet recruiting.

Status: Recruiting
Study area: Chronic Disease
Principal investigator: Ryan Bradley, ND, MPH
Co-investigator(s): Marisa Pellegrini, ND
Funded by: Faculty Seed Grant
Project period: 4/1/13-6/30/14

This study will evaluate quercitin’s effects on blood glucose and blood vessel function (endothelial function) in patients with type 2 diabetes in comparison to placebo and Acarbose, a pharmaceutical anti-diabetic agent.

Status: Completed
Study area: Oncology
Principal investigator: Hailing Lu (University of Washington)
Co-investigator(s): Cynthia Wenner, PhD
Project period: April 2010 – March 2014

Clinical management of locally advanced breast cancer remains challenging as patients have a high risk for relapse, especially those patients whose tumors over-express the HER-2/neu (HER2+) oncogenic protein and have limited expression of estrogen receptors (ER-).

Status: Completed
Study area: General Wellness, Other
Principal investigator: Jason Allen, ND, MPH
Funded by: NIH/NCCAM
Project period: 07/01/13-04/30/14

The primary goal of this study is to conduct a methodologically rigorous investigation of a hyperthermia-based, medically monitored, detoxification protocol in order to assess the impact of sauna use on potential reductions in blood polychlorinated biphenyls (PCB) concentrations.

Status: Active
Study area: Neurology
Principal investigator: Laurie Mischley, ND
Project period: January 2010 – December 2014

Parkinson's disease (PD) is considered a progressive and irreversible neurodegenerative disease. Current therapies improve disease symptoms, however none alter the underlying degenerative course.

Pages